Alessandro Ferrari

Dr. Alessandro Ferrari

Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AGAdrian Gervais
Adrian Gervais
FRFrancesca Rovida
Francesca Rovida
SCStefania Croce
Stefania Croce
SCStefania Croce
Stefania Croce
AMAstrid Marchal
Astrid Marchal
ABAlessandro Borghesi
Alessandro Borghesi
Mosquito-borne West Nile virus (WNV) infection is benign in most individuals but can cause encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for WNV disease (WNVD) in six independent cohorts from the EU and USA carry auto-Abs neutralizing IFN-α and/or -ω. The prevalence of these antibodies is highest in patients with encephalitis (∼40%), and that in individuals with silent WNV infection is as low as that in the general population. The odds ratios for WNVD in individuals with these auto-Abs relative to those without them in the general population range from 19.0 (95% CI 15.0–24.0, P value <10–15) for auto-Abs neutralizing only 100 pg/ml IFN-α and/or IFN-ω to 127.4 (CI 87.1–186.4, P value <10–15) for auto-Abs neutralizing both IFN-α and IFN-ω at a concentration of 10 ng/ml. These antibodies block the protective effect of IFN-α in Vero cells infected with WNV in vitro. Auto-Abs neutralizing IFN-α and/or IFN-ω underlie ∼40% of cases of WNV encephalitis.

1 November 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
AGAdrian Gervais
Adrian Gervais
PBPaul Bastard
Paul Bastard
LBLucy Bizien
Lucy Bizien
CDCéline Delifer
Céline Delifer
PTPierre Tiberghien
Pierre Tiberghien
JCJean-Laurent Casanova
Jean-Laurent Casanova
Arboviral diseases are a growing global health concern. Pre-existing autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) can underlie encephalitis due to West Nile virus (WNV) (∼40% of patients) and tick-borne encephalitis (TBE, due to TBE virus [TBEV]) (∼10%). We report here that these auto-Abs can also underlie severe forms of rarer arboviral infections. Auto-Abs neutralizing high concentrations of IFN-α2, IFN-β, and/or IFN-ω are present in the single case of severe Powassan virus (POWV) encephalitis studied, two of three cases of severe Usutu virus (USUV) infection studied, and the most severe of 24 cases of Ross River virus (RRV) disease studied. These auto-Abs are not found in any of the 137 individuals with silent or mild infections with these three viruses. Thus, auto-Abs neutralizing type I IFNs underlie an increasing list of severe arboviral diseases due to Flaviviridae (WNV, TBEV, POWV, USUV) or Togaviridae (RRV) viruses transmitted to humans by mosquitos (WNV, USUV, RRV) or ticks (TBEV, POWV).

28 October 2021 in Viruses
Verified
Journal Article
Open access
PDF file
EPElena Percivalle
Elena Percivalle
JSjosè camilla sammartino
josè camilla sammartino
ICIrene Cassaniti
Irene Cassaniti
EAEloisa Arbustini
Eloisa Arbustini
MUMario Urtis
Mario Urtis
Fausto BaldantiFausto Baldanti
Fausto Baldanti
We aimed to explore whether variants of SARS-CoV-2 (Chinese-derived strain (D614, lineage A), Italian strain PV10734 (D614G, lineage B.1.1) and Alpha strain (lineage B.1.1.7)) were able to infect monocytes (MN) and monocyte-derived macrophages (MDM) and whether these infected cells may, in turn, be vectors of infection. For this purpose, we designed an in vitro study following the evolution of MN and MDM infection at different time points in order to confirm whether these cells were permissive for SARS-CoV-2 replication. Finally, we investigated whether, regardless of viral replication, the persistent virus can be transferred to non-infected cells permissive for viral replication. Thus, we co-cultured the infected MN/MDM with permissive VERO E6 cells verifying the viral transmission. This is a further in vitro demonstration of the important role of MN and MDM in the dissemination of SARS-CoV-2 and evolution of the COVID-19 disease.

9 May 2023 in Journal of Medical Virology
Verified
Journal Article
Open access
JSjosè camilla sammartino
josè camilla sammartino
ICIrene Cassaniti
Irene Cassaniti
AFAlessandro Ferrari
Alessandro Ferrari
APAntonio Piralla
Antonio Piralla
FBFederica Bergami
Federica Bergami
Fausto BaldantiFausto Baldanti
Fausto Baldanti
Monkeypox virus (MPXV) is a zoonotic disease endemic in the rainforest countries of Central and West Africa. Understanding the immune response in zoonosis is fundamental to prevent and contrast viral spreading. MPXV is a close relative of Variola (smallpox) virus and vaccination with vaccinia virus gives approximatively 85% of protection against MPXV. With the emergence of the recent MPXV outbreak, JYNNEOS vaccine has been proposed to individuals at high‐risk of exposure. Comparative data on MPXV immune response in vaccinated or infected subjects are still limited. Here we set‐up an immunofluorescence method for the evaluation of humoral response elicited by natural infection and healthy vaccinated subjects, including historically smallpox‐vaccinated individuals and newly vaccinated subjects. Neutralization assay was also included, and in vaccinated subjects, cell‐mediated response was evaluated. We observed that the natural infection produces a strong immune response that can control the disease. In naïve subjects, a second dose boosts the serological response to levels similar to those of the MPXV patients. Last, smallpox‐vaccinated controls retain a degree of protection, even after years from vaccination, most visible in the t‐cellular response.

11 November 2021 in Viruses
Verified
Journal Article
Open access
PDF file
FZFederica Zavaglio
Federica Zavaglio
VFVanessa Frangipane
Vanessa Frangipane
MMMonica Morosini
Monica Morosini
EGElisa Gabanti
Elisa Gabanti
ZPZelini Paola
Zelini Paola
Fausto BaldantiFausto Baldanti
Fausto Baldanti
The development and persistence of SARS-CoV-2-specific immune response in immunocompetent (IC) and immunocompromised patients is crucial for long-term protection. Immune response to SARS-CoV-2 infection was analysed in 57 IC and 15 solid organ transplanted (TX) patients. Antibody responses were determined by ELISA and neutralization assay. T-cell response was determined by stimulation with peptide pools of the Spike, Envelope, Membrane, and Nucleocapsid proteins with a 20-h Activation Induced Marker (AIM) and 7-day lymphoproliferative assays. Antibody response was detected at similar levels in IC and TX patients. Anti-Spike IgG, IgA and neutralizing antibodies persisted for at least one year, while anti-Nucleocapsid IgG declined earlier. Patients with pneumonia developed higher antibody levels than patients with mild symptoms. Similarly, both rapid and proliferative T-cell responses were detected within the first two months after infection at comparable levels in IC and TX patients, and were higher in patients with pneumonia. T-cell response persisted for at least one year in both IC and TX patients. Spike, Membrane, and Nucleocapsid proteins elicited the major CD4+ and CD8+ T-cell responses, whereas the T-cell response to Envelope protein was negligible. After SARS-CoV-2 infection, antibody and T-cell responses develop rapidly and persist over time in both immunocompetent and transplanted patients.

17 April 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
GRGreta Romano
Greta Romano
AFAlessandro Ferrari
Alessandro Ferrari
FBFausto Baldanti
Fausto Baldanti
In the 20th and 21st centuries, humanity has faced several global crises, including world wars, the 1918 Spanish flu, and the recent COVID-19 pandemic. Notably, the COVID-19 pandemic caused significant mortality, particularly among older adults, while younger ages were less affected. Strikingly, according to the Italian National Institute of Statistics (Istat), centenarians (aged 100 and above) in Italy experienced no significant increase in mortality in 2020. This retrospective study hypothesizes that elderly people may have developed an immune response that offered protection against COVID-19, potentially linked to their exposure to a specific past infectious event. We examined historical mortality data from 1872 to 2021 and performed phylogenetics analysis on sequencing data to explore the possibility that centenarians may have encountered another Coronavirus (misidentified as Russian Flu), which could have contributed to their resilience. This research provides insights into the adaptive responses of the most vulnerable populations, symbolically comparing them to the “left-standing trees” following catastrophic events.